An interview with Director Miyazaki titled "AIM Cat Drug nears practical use. Call for participation in a fact-finding survey ―Interview with Toru Miyazaki, Director of Institute for AIM Medicine" has　≫read more

Our recently published paper has been featured in JIJI.COM news. Serum AIM protein as a diagnostic marker for chronic kidney disease: a potential tool for determining dialysis initiation (Issued on J　≫read more

A special feature article titled "Director Miyazaki at The Institute for AIM Medicine is developing a protein drug for feline kidney disease" has been published on Nikkei Biotech ONLINE.　≫read more

An interview article featuring Director Toru Miyazaki “A Promising Breakthrough: Unveiling the AIM Drug Revolutionizing Feline Kidney Disease by Eliminating Body 'Garbage'” has been published in Newsw　≫read more

The article published recently regarding Rheumatoid Arthritis has been featured in JIJI.COM News. ‘Breakthrough in Rheumatoid Arthritis Treatment: AIM Protein Shows Effectiveness, Bringing Hope for 　≫read more

Interview with Director Miyazaki appears in ‘Nekomaga’ published in Kitten Breeder NAVI.

Shueisha Online publishes an article excerpted and rearranged from Director Miyazaki's book, "The Day Cats Live to be 30 Years Old.　≫read more

An interview with Director Miyazaki titled "The Mechanism of AI Resembles an Orchestra Performance" will be featured in the Yomiuri Shimbun Online column "Nyanko-logy" (felinology)　≫read more

Director Miyazaki was featured in the section "Kotoba no album" of Yomiuri Newspaper (Evening Edition) on June 2, 2023.

An interview article titled "Extending the Lifespan of Cats to 30 Years! Former University of Tokyo Professor Develops Groundbreaking Medicine and Reveals the 'Reasons'" by Director Miyazaki has been 　≫read more